磺胺类碳酸酐酶抑制剂研究进展

被引：18

作者：

宋春泽 ^{[1
]}

周成合 ^{[1
]}

袁勇 ^{[2
]}

机构：

[1] 西南大学化学化工学院

[2] 重庆医科大学药学院

来源：

中国新药杂志 | 2007年 / 18期

关键词：

磺胺; 碳酸酐酶抑制剂; 抗青光眼; 抗肿瘤;

D O I：

暂无

中图分类号：

R98 [各科药物];

学科分类号：

1007 ;

摘要：

碳酸酐酶抑制剂(CAIs)作为药物具有广泛的生物活性,如抗青光眼、利尿、抗肿瘤、抗癫痫、抗风湿、降血糖等。近几年,新一代抗青光眼磺胺类CAIs已经取得很大的研究成果,抗肿瘤磺胺类CAIs的研究也日益活跃,发展极为迅速。现综述磺胺类CAIs在抗青光眼和抗肿瘤领域的研究进展。

引用

页码：1438 / 1444

页数：7

共 17 条

[1] 用作抗青光眼药物的碳酸酐酶抑制剂 [J].

姚忠 ;

江程 ;

李津申 ;

胡建强 ;

尤启冬 .

药学进展, 2002, (04) :202-205

[2]

Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with sulfonylated hydroxamates[J] . Elisa Nuti,Elisabetta Orlandini,Susanna Nencetti,Armando Rossello,Alessio Innocenti,Andrea Scozzafava,Claudiu T. Supuran.Bioorganic ＆ Medicinal Chemistry . 2007 (6)

[3]

Carbonic anhydrase inhibitors: Inhibition of cytosolic/tumor-associated isoforms I, II, and IX with iminodiacetic carboxylates/hydroxamates also incorporating benzenesulfonamide moieties[J] . M. Amelia Santos,Sergio Marques,Daniela Vullo,Alessio Innocenti,Andrea Scozzafava,Claudiu T. Supuran.Bioorganic ＆ Medicinal Chemistry Letters . 2007 (6)

[4]

Carbonic anhydrase inhibitors. Synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with boron-containing sulfonamides, sulfamides, and sulfamates: Toward agents for boron neutron capture therapy of hypoxic tumors[J] . Jean-Yves Winum,Alessandro Cecchi,Jean-Louis Montero,Alessio Innocenti,Andrea Scozzafava,Claudiu T. Supuran.Bioorganic ＆ Medicinal Chemistry Letters . 2005 (13)

[5]

Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff’s bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes[J] . Luca Puccetti,Giuseppe Fasolis,Daniela Vullo,Zahid H. Chohan,Andrea Scozzafava,Claudiu T. Supuran.Bioorganic ＆ Medicinal Chemistry Letters . 2005 (12)

[6]

Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II, and IX with a series of 1,3,4-thiadiazole- and 1,2,4-triazole-thiols[J] . Gabriela Laura Almajan,Alessio Innocenti,Luca Puccetti,Gheorghe Manole,Stefania Barbuceanu,Ioana Saramet,Andrea Scozzafava,Claudiu T. Supuran.Bioorganic ＆ Medicinal Chemistry Letters . 2005 (9)

[7]

Carbonic anhydrase inhibitors: Inhibition of the tumor-associated isozymes IX and XII with polyfluorinated aromatic/heterocyclic sulfonamides[J] . Silvia Pastorekova,Daniela Vullo,Angela Casini,Andrea Scozzafava,Jaromir Pastorek,Isao Nishimori,Claudiu T. Supuran.Journal of Enzyme Inhibition and Medicinal Chemis . 2005 (3)

[8]

Carbonic anhydrase inhibitors: Topically acting antiglaucoma sulfonamides incorporating esters and amides of 3- and 4-carboxybenzolamide[J] . Angela Casini,Andrea Scozzafava,Francesco Mincione,Luca Menabuoni,Michele Starnotti,Claudiu T Supuran.Bioorganic ＆ Medicinal Chemistry Letters . 2003 (17)

[9]

Cyclodextrin Complexes of Sulfonamide Carbonic Anhydrase IOnhibitors As Long‐lasting Topically Acting Antiglaucoma Agents[J] . Francesca Maestrelli,Paola Mura,Angela Casini,Francesco Mincione,Andrea Scozzafava,Claudiu T. Supuran.Journal of Pharmaceutical Sciences . 2002 (10)

[10] Carbonic anhydrase inhibitors with strong topical antiglaucoma properties incorporating a 4-(2-aminopyrimidin-4-yl-amino)-benzenesulfonamide scaffold [J].

Casini, A ;

Mincione, F ;

Vullo, D ;

Menabuoni, L ;

Scozzafava, A ;

Supuran, CT .

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2002, 17 (01) :9-18

← 1 2 →